Table 3 Genetically engineered mouse models of gastric cancer.
GEMM | References |
|---|---|
K19-Kras-V12 TG | Brembeck et al., 2003 |
K19-Kras-V12 TG | Okumura et al., 2010 |
K19-CreERT; LSL-KrasG12D/+ | Ray et al., 2011 |
Ubc9 Cre-ERT2; LSL-KrasG12D/+ | Matkar et al., 2011 |
Mist1-CreERT2; LSL-KrasG12D/+ | Choi et al., 2016 |
eR1-CreERT2; LSL-KrasG12D/+ | Matsuo et al., 2017 |
Atp4b-Cre; LSL-KrasG12D/+; Cdh1fl/fl; Trp53fl/fl | Till et al., 2017 |
Tff1-Cre; LSL-KrasG12D/+ | Kinoshita et al., 2019 |
Tff1-Cre; LSL-KrasG12D/+;Ptenfl/fl | |
Anxa10-CreERT2; LSL-KrasG12D/+;LSL-Tp53R172H/+;Smad4fl/fl | Seidlitz et al., 2019 |
Anxa10-CreERT2; LSL-KrasG12D/+;Cdh1fl/fl;Smad4fl/fl | |
Anxa10-CreERT2; LSL-KrasG12D/+;Cdh1fl/fl;Apcfl/fl | |
Lrig1-CreERT2; LSL-KrasG12D/+ | Choi et al., 2019 |
Iqgap3-CreERT2; LSL-KrasG12D/+ | Matsuo et al., 2021 |
Pgc-CreERT2; LSL-KrasG12D/+ | Douchi et al., 2021 |
Pgc-CreERT2; LSL-KrasG12D/+; Apcfl/fl | |
Pgc-CreERT2; LSL-KrasG12D/+; Apcfl/fl;Trp53fl/+ or fl/fl | |
Cldn18-CreERT2; LSL-KrasG12D/+ | Fatehullah et al., 2021 |
Cldn18-CreERT2; LSL-KrasG12D/+;Apcfl/fl | |
Cldn18-CreERT2; LSL-KrasG12D/+;Trp53fl/fl | |
Cldn18-CreERT2; LSL-KrasG12D/+;Apc fl/+ or fl/fl;Trp53fl/fl |
